Building Capacity for Active Surveillance of Vaccine Adverse Events in Low and Middle-Income Countries


Por: Sturkenboom, M, Perez-Vilar, S, Weibel, D, Black, S, Maure, C, Castro, J, Bravo-Alcantara, P, Dodd, C, Romio, S, de Ridder, M, Nakato, S, Molina, H, Elango, V and Zuber, P

Publicada: 1 ago 2017
Resumen:


Filiaciones:
Sturkenboom, M:
 Erasmus Univ, Med Ctr, Rotterdam, Netherlands

 Vaccine GRID Fdn, Basel, Switzerland

:
 Erasmus Univ, Med Ctr, Rotterdam, Netherlands

 FISABIO, Fdn Fomento Invest Sanitaria & Biomed Comunitat, Valencia, Spain

Weibel, D:
 Erasmus Univ, Med Ctr, Rotterdam, Netherlands

 Vaccine GRID Fdn, Basel, Switzerland

Black, S:
 Vaccine GRID Fdn, Basel, Switzerland

 Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA

Maure, C:
 WHO, Geneva, Switzerland

Castro, J:
 WHO, Pan Amer Hlth Org, Washington, DC USA

Bravo-Alcantara, P:
 WHO, Pan Amer Hlth Org, Washington, DC USA

Dodd, C:
 Erasmus Univ, Med Ctr, Rotterdam, Netherlands

Romio, S:
 Erasmus Univ, Med Ctr, Rotterdam, Netherlands

 Univ Milano Bicocca, Milan, Italy

de Ridder, M:
 Erasmus Univ, Med Ctr, Rotterdam, Netherlands

Nakato, S:
 Erasmus Univ, Med Ctr, Rotterdam, Netherlands

Molina, H:
 WHO, Pan Amer Hlth Org, Washington, DC USA

Elango, V:
 WHO, Geneva, Switzerland

Zuber, P:
 WHO, Geneva, Switzerland
ISSN: 10538569





PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Meeting Abstract
Volumen: 26 Número:
Páginas: 241-242
WOS Id: 000437103900396

MÉTRICAS